Papers/PMID:10693368
Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee.
The Western journal of medicine2000The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
glucosamine — no detected effect on visual analogue scale pain intensity
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“There was no statistical difference between the two groups in scores on the visual analog scale at 30 days for resting (mean [SD] score placebo group 3.5 [2.7] vs 3.3 [2.4] glucosamine group, P = 0.66) or walking (5.1 [2.6] vs 5.3 [2.4], P = 0.69); there was also no difference at 60 days for resting (3.4 [2.5] vs 3.2 [2.5], P = 0.81) or walking (4.9 [2.2] vs 4.9 [2.8], P = 0.90).”
Quoted verbatim from Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee.. - Study
- RCT
- Duration
- 2 months
- Dose
- glucosamine 500 mg three times daily (salt not stated in abstract)
- Population
- patients aged 34 to 81 being treated for osteoarthritis of the knee at a Veterans Affairs Medical Center; pain at rest and while walking, at 30 and 60 days
Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee.2000PMID:10693368Permalink